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ABSTRACT Multidrug efflux pumps provide clinically significant levels of drug resistance in a number of Gram-negative
hospital-acquired pathogens. These pathogens frequently carry dozens of genes encoding putative multidrug efflux pumps.
However, it can be difficult to determine howmany of these pumps actually mediate antimicrobial efflux, and it can be even
more challenging to identify the regulatory proteins that control expression of these pumps. In this study, we developed an inno-
vative high-throughput screening method, combining transposon insertion sequencing and cell sorting methods (TraDISort), to
identify the genes encoding major multidrug efflux pumps, regulators, and other factors that may affect the permeation of anti-
microbials, using the nosocomial pathogen Acinetobacter baumannii. A dense library of more than 100,000 unique transposon
insertionmutants was treated with ethidium bromide, a common substrate of multidrug efflux pumps that is differentially fluo-
rescent inside and outside the bacterial cytoplasm. Populations of cells displaying aberrant accumulations of ethidiumwere
physically enriched using fluorescence-activated cell sorting, and the genomic locations of transposon insertions within these
strains were determined using transposon-directed insertion sequencing. The relative abundance of mutants in the input pool
compared to the selected mutant pools indicated that the AdeABC, AdeIJK, and AmvA efflux pumps are the major ethidium ef-
flux systems in A. baumannii. Furthermore, the method identified a new transcriptional regulator that controls expression of
amvA. In addition to the identification of efflux pumps and their regulators, TraDISort identified genes that are likely to control
cell division, cell morphology, or aggregation in A. baumannii.
IMPORTANCE Transposon-directed insertion sequencing (TraDIS) and related technologies have emerged as powerful methods
to identify genes required for bacterial survival or competitive fitness under various selective conditions. We applied
fluorescence-activated cell sorting (FACS) to physically enrich for phenotypes of interest within a mutant population prior to
TraDIS. To our knowledge, this is the first time that a physical selection method has been applied in parallel with TraDIS rather
than a fitness-induced selection. The results demonstrate the feasibility of this combined approach to generate significant results
and highlight the major multidrug efflux pumps encoded in an important pathogen. This FACS-based approach, TraDISort,
could have a range of future applications, including the characterization of efflux pump inhibitors, the identification of regula-
tory factors controlling gene or protein expression using fluorescent reporters, and the identification of genes involved in cell
replication, morphology, and aggregation.
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To be effective in killing or stalling the growth of bacterial cells,antimicrobialsmust reach their cellular targets. For themajor-
ity of antimicrobials, these targets are in the cytoplasm, meaning
that they must cross the cell envelope to induce their effects. The
cell envelope is a particularly important factor for antimicrobial
resistance in Gram-negative bacteria, since it includes two mem-
brane permeability barriers with different surface chemistries,
presenting significant potential to limit the accumulation of
chemically diverse antimicrobial compounds (1).
In addition to preventing accumulation of antimicrobials, all
bacteria employ sets of efflux pumps that mediate the active ex-
pulsion of these compounds should they cross a biological mem-
brane (2).Many antimicrobial efflux pumps in bacteria havemul-
tidrug recognition profiles. Therefore, the increased expression of
a single pump can result in resistance to a broad spectrum of
antimicrobial classes. In Gram-negative bacteria, efflux pump
overexpression has been shown to promote clinically significant
levels of antimicrobial resistance (3). Genes encoding efflux
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pumps have been identified in all bacterial genomes sequenced to
date and can be found in large numbers (4). For example, strains
of the opportunistic human pathogen Acinetobacter baumannii
typically encode more than 50 putative efflux pumps, accounting
for approximately 1.5% of their protein coding potential (5).
Despite their abundance, only a few transporters resembling
drug efflux pumps have been experimentally characterized in
most bacterial species. It can be difficult to discernwhich, if any, of
the uncharacterized pumps could play an active role in protecting
the cell against cytotoxic compounds without conducting labor-
intensive experimental investigations. Furthermore, it can be even
more challenging to identify the regulatory proteins that control
expression of active multidrug efflux pumps. In this study, we
sought to identify these proteins in A. baumannii by directly as-
sessing drug accumulation within a population of more than
100,000 random transposon mutants. To this end, we applied
fluorescence-activated cell sorting (FACS) in parallel with
transposon-directed insertion sequencing (TraDIS) (6, 7). This
novel approach, which we have named “TraDISort,” was able to
identify genes in A. baumannii that are associated with increased
or decreased accumulation of ethidium bromide, a cationic qua-
ternary ammonium derivative and a common substrate of multi-
drug efflux pumps.
Fluorescence-activated cell sorting to enrich formutantsdis-
playing aberrant accumulation of ethidium. Ethidium readily
intercalates into nucleic acids, whereupon its fluorescence inten-
sity increases significantly. Consequently, ethidium is differen-
tially fluorescent inside and outside cells, and cellular fluorescence
can be used as a proxy for its cytoplasmic concentration (8). We
hypothesized that when cells are treated with a subinhibitory con-
centration of ethidium, the ethidium concentrations in the cyto-
plasmof cells with defectivemultidrug effluxmachinery should be
higher than the concentration in wild-type cells at equilibrium,
and conversely, the concentration in cells with overactive efflux
machinery should be below that in wild-type cells To test this
hypothesis, we examined populations of three isogenic strains of
A. baumannii AB5057-UW (9) that differentially expressed Ad-
eIJK, a major multidrug efflux pump in A. baumannii, which rec-
ognizes ethidium as a substrate (10, 11): (i) wild-type AB5075-
UW, (ii) a mutant containing a transposon insertion in adeJ, and
(iii) a mutant containing a transposon insertion in adeN, which
encodes a negative regulator of adeIJK expression (9). When ex-
amined by flow cytometry, populations of the different cell types
displayed distinct but partially overlapping fluorescence profiles
that were in agreement with our predictions, i.e., the average flu-
orescence of the adeJ and adeNmutant populationswas above and
below that of the wild-type population, respectively (see Fig. S1A
in the supplementalmaterial).We repeated this experiment, using
equivalent isogenic strains of Acinetobacter baylyi ADP1 (5), and
made the same observations (see Fig. S1B). Based on these exper-
iments, we predicted that it would be possible to use FACS to
enrich cells from a large mutant pool that display differential
ethidium accumulation or efflux based on their fluorescence in-
tensity.
A mutant library containing more than 100,000 unique inser-
tionmutants ofA. baumannii BAL062 was generated using a Tn5-
based custom transposon, and the insertion sites in the mutant
pool were mapped by TraDIS (7). This library was treated with 40
M ethidium bromide (1/16 MIC of the parental strain) and
subjected to FACS to collect cells containing the highest concen-
trations of ethidium (i.e., the 2% most fluorescent cells) and cells
containing the lowest concentrations of ethidium (i.e., the 2%
least fluorescent cells). DNA was isolated from the selected pools
of cells, and TraDIS was used to identify the chromosomal loca-
tions of the Tn5 insertion sites in these cells (7). Transposon in-
sertions were significantly (2-fold change; Q value, 0.05) less
abundant in 162 genes and more abundant in 24 genes in the
low-fluorescence population and less abundant in 159 genes and
more abundant in 24 genes in the high-fluorescence population
compared to the input pool (see Data Set S1 in the supplemental
material).
FACS in parallel with TraDIS identifies the active ethidium
efflux pumps encoded by A. baumannii and core efflux pump
regulators. Following the experiments with targeted mutants, we
hypothesized that many cells containing the highest concentra-
tions of ethidium would have transposon insertions in genes en-
coding efflux pumps or activators of efflux pumps, and con-
versely, cells containing the lowest concentrations of ethidium
would have insertions in genes encoding negative regulators of
efflux pumps. Comparisons of the insertion sites in the mutant
input pool with those in the high- and low-fluorescence pools
supported this proposal (Fig. 1; see also Data Set S1 in the supple-
mental material). Mutants carrying insertions in genes encoding
several multidrug efflux pumps, particularly adeABC (12), adeIJK
(10), and amvA (13, 14), and genes encoding the adeABC activa-
tor, adeRS (15), were overrepresented in the highly fluorescent
populations (Fig. 1). Inactivation of these genes is likely to reduce
the rate of efflux and thus result in a higher cytosolic concentra-
tion of ethidium. In contrast, inactivated mutants of these genes
were less abundant in the low-fluorescence populations (Fig. 1),
since the efflux pumps encoded or regulated by these genes help
to lower the concentration of ethidium in the cell. We used the
FIG 1 Selection of A. baumanniimutants carrying insertions in genes encod-
ing the characterized efflux pumps AdeABC (12), AdeIJK (10), AdeFGH (20),
AmvA (13, 14), CraA (21), AbeS (22), AbeM (23), and AceI (24, 25) and
regulators AdeRS and BaeRS, which control expression of adeABC (15, 26);
AdeN, which controls adeIJK (16); AdeL, which controls adeFGH (20); and
AceR,which controls aceI (27). Bars represent the fold change inmutant abun-
dance in cells selected for low ethidium fluorescence (blue), high ethidium
fluorescence (red), or growth in 62.5g/ml (approximately 158M)ethidium
bromide (hatched green; 1/4 MIC) compared to the starting mutant pool.
Positive values indicate highermutant abundance in the selected pool, whereas
negative values indicate lower abundance. Asterisks indicate values supported
by aQ value of 0.05 or below. ¶, the gene named here as amvR encodes a TetR
family regulator that represses amvA gene expression (see text for details).
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Transporter Automated Annotation Pipeline (http://www
.membranetransport.org/) to search for genes encoding novel ef-
flux pumps in theA. baumanniiBAL062 genome.We identified 56
genes that are likely to encode novel efflux pumps, or components
of novel efflux pumps, based on their primary sequence charac-
teristics (see Table S1 in the supplemental material). These efflux
pumps are likely to recognize small-molecule substrates, but our
data did not suggest that any of these efflux pumps have a signif-
icant in vivo role in ethidium efflux, since none were significantly
differentially selected by our fluorescence-based selection (see Ta-
ble S1).
Some of the most highly differentially selected genes in the
flow-sorted samples were genes that encode transcriptional re-
pressors known or predicted to control expression of multidrug
efflux systems. For example, mutants carrying insertions in adeN,
which controls expression of adeIJK (16), were 1,469-fold less
abundant in the highly fluorescent output pool compared to the
input pool (Fig. 1). Additionally, mutants carrying insertions in
BAL062_01495, which encodes a TetR family regulator, were 371-
fold less abundant in the highly fluorescent output pool compared
to the input pool (Fig. 1). BAL062_01495 is adjacent to and diver-
gently transcribed from amvA in the BAL062 chromosome. To
test whether the TetR family protein encoded by BAL062_01495
was able to regulate expression of amvA, we compared amvA ex-
pression levels in the A. baumannii AB5075-UW parental strain
and a strain harboring a transposon insertion in the gene ortholo-
gous to BAL062_01495. The level of amvA expression measured
by reverse transcription-quantitative PCR (qRT-PCR) (5) in the
mutant strain was 5.7- 1.9-fold higher than that in the parental
strain during late exponential phase, indicating that the TetR fam-
ily regulator controls expression of amvA. Consequently, we have
tentatively named this novel regulator AmvR.
To confirm the specific involvement of different multidrug
efflux pumps and their regulators in controlling the accumulation
of ethidium in A. baumannii, we conducted flow cytometry on
targeted mutants of adeB, adeR, adeJ, adeN, adeG, adeL, amvA,
amvR, craA, abeS, and abeM. These mutant strains were loaded
with 40 M ethidium bromide, and the fluorescence of 10,000
cells was determined by flow cytometry (Fig. 2). The TraDISort
method identified the AdeABC, AdeIJK, and AmvA efflux systems
and their regulators, AdeRS, AdeN, and AmvR, as playing a role in
ethidium accumulation. The fluorescence profiles of the specific
mutant populations closely reflected these findings. As seen in our
preliminary experiments (see Fig. S1 in the supplemental mate-
rial), the average fluorescence of the adeJ and adeN mutant pop-
ulations was above and below that of the parental cell population,
respectively (Fig. 2B). The amvA and amvR mutant cells showed
fluorescence profiles very similar to those of adeJ and adeN mu-
tants, respectively (Fig. 2D), in line with the function of AmvR as
a repressor of amvA expression. The average fluorescence of the
adeB and adeRmutant cell populationswas a similar degree higher
than that of the parental population, highlighting the role of AdeB
in ethidium efflux and of AdeR in controlling the expression of
adeABC (Fig. 2A). The fluorescence profiles of mutant popula-
tions of other multidrug efflux systems, which were not identified
using the TraDISort approach, were very similar to that of the
parental strain (Fig. 2).
TraDIS following fitness-induced selection using ethidium
bromide. In addition to FACS to enrich for cells displaying aber-
rant accumulation of ethidium, we cultured the mutant library in
the presence of ethidium bromide. This experiment used a higher
concentration of ethidium bromide (1/4 MIC of the parental
strain) than that used in the FACS analyses to impose a chemical
selection that would allow us to identify mutants with a fitness
advantage or defect in the presence of ethidium by TraDIS. In the
ethidium bromide-selected mutant pools, transposon insertions
were less abundant in 63 genes and more abundant in eight genes
compared with the input control pools. This suggests that gene
loss generally results in a fitness defect, rather than advantage,
under ethidium selection, which is in keeping with general evolu-
tionary theory. Mutants containing transposon insertions in ef-
flux pump genes and their regulators were the most highly differ-
entially selected by ethidium bromide. The pattern of selection
among these mutants overlapped with the selection pattern in the
low-ethidium-fluorescence FACS experiment (Fig. 1). For exam-
ple, mutants carrying transposon insertions in the adeABC, ad-
eIJK, amvA, and adeRS genes were less abundant in the ethidium-
FIG 2 Flow cytometric analysis of Acinetobacter baumannii AB5075-UW
parental strain (black), inactivated efflux pump mutants (blue), and inacti-
vated efflux regulatory mutants (red). The fluorescence profile of the parental
population is shown in all panels and is overlaid with the profiles ofadeB and
adeR (A), adeJ and adeN (B), adeG and adeL (C), amvA and amvR
(D), craA (E), abeS (F), and abeM (G). Cell populations were exposed to
40Methidium bromide, and each curve shows the fluorescence intensity for
10,000 cells. The cell populations show distinct fluorescence profiles based on
the concentration of ethidium in the cell cytoplasm.
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selected output pool (Fig. 1), confirming the role of these
multidrug efflux pumps and regulators in resistance to ethidium.
Similarly to efflux pump genes and their regulators, mutations
in the DNA modification methylase gene, BAL062_03687, were
significantly negatively selected by ethidium bromide and less
abundant in the low-fluorescence samples compared to the input
pool. Methylation mediated by BAL062_03687 could protect
DNA from ethidium intercalation and thereby reduce fluores-
cence and provide resistance to ethidium-induced mutation.
Several genes controlling the composition of the cell mem-
branes, cell wall, or capsule were also negatively selected by
ethidium bromide (BAL062_00585, BAL062_00596, BAL062_01038,
BAL062_03374, BAL062_03418, BAL062_03480, BAL062_03481,
BAL062_03674, and BAL062_03869 [see Data Set S1 in the sup-
plemental material]). These genes may help to reduce uptake of
ethidium. Some of these genes were significantly negatively se-
lected in both the low- and high-fluorescence FACS-selected sam-
ples and could thus play a role in controlling cell morphology or
size (see below). In contrast, several capsule biosynthesis genes
(BAL062_03853, BAL062_03857, and BAL062_03858) were pos-
itively selected by the ethidium treatment. This highlights the in-
fluence that the sugar composition of the capsule could play in
regulating the accumulation of amphipathic small molecules into
the cell.
FACS inparallelwithTraDIS identifies genes involved in cell
division and aggregation. In conducting FACS to enrich for mu-
tants displaying aberrant accumulation of ethidium in A. bau-
mannii, we gated to target cells with uniform forward and side
scatter and limited the collection of dead or aggregated cells that
may complicate downstream analyses (see Fig. S2 in the supple-
mental material). As a consequence of this gating, we identified a
number of mutants that are likely to have cell division defects or
enhanced aggregation properties. These mutants were negatively
selected in both the low- and high-fluorescence FACS-selected
pools relative to the input pool, and included 80 (49.4 to 50.3%) of
the significantly selected genes in these pools. For example, mu-
tants carrying insertions in the mreBCD gene cluster (BAL062_
00713 to BAL062_00715), rlpA (BAL062_01224), rodA (BAL062_
01226), and ftsI (BAL062_02811), which are likely to function in
cell division, were in very low abundance in each of the flow-
sorted mutant pools relative to the input pool (see Fig. S3). Mu-
tants carrying insertions in biotin biosynthesis genes were also
significantly less abundant in the FACS-selected pools than in the
input pool and, to a lesser extent, in the ethidium-selected pools.
The role of biotin in ethidium resistance, cell structure, or aggre-
gation is at present unknown but may be related to its function as
a cofactor in fatty acid synthesis. Two capsular polysaccharide
biosynthetic genes were significantly less abundant in both of the
flow-sorted mutant pools than in the input pool. These mutants
may have a higher tendency toward aggregation or different cell
morphologies or may display light-scattering properties different
from those of othermutant cells (see Fig. S3). Approximately 20%
of the inactivated genes in mutants negatively selected by FACS
were annotated as hypothetical proteins, andmanymore had been
assigned only putative functions. These genes could be targeted in
future investigations exploring cell division and aggregation/bio-
film formation in A. baumannii.
While insertions in genes implicated in cell replication and
increased aggregation were negatively selected by the flow sorting,
there appeared to be enrichment for mutants that are less likely to
aggregate in culture. The majority of these mutants harbored
transposon insertions in the csu type I pilus biosynthesis and reg-
ulatory gene cluster (BAL062_01328 to BAL062_01334 [see
Fig. S4 in the supplemental material]). These genes are likely to
function in biotic or abiotic cell adherence/aggregation and bio-
film formation (17). Therefore, we suspect that the strains carry-
ing mutations in these genes are less likely to aggregate, leading to
their enrichment in our flow-sorted samples.
Conclusions. In this study, we identified the genes that control
accumulation of the antimicrobial dye ethidium into the Gram-
negative hospital-associated pathogen A. baumannii. We ex-
ploited the differential fluorescence of ethidium inside and out-
side the cell to enrich formutants showing aberrant accumulation
of ethidium by FACS and used TraDIS to identify the transposon
insertion sites within the enrichedmutants. This work highlighted
the importance of three multidrug efflux systems, AdeABC, Ad-
eIJK, and AmvA, in reducing ethidium accumulation and pro-
moting resistance. We also confirmed the importance of two reg-
ulatory systems, AdeRS and AdeN, that control expression of two
of these pumps and identified the first known regulator for the
AmvA efflux pump, which we have called AmvR. These results
demonstrate the utility of the TraDISort method in identifying
bacterial multidrug resistance efflux pumps and will be particu-
larly useful when studying bacterial species for which little is
known with respect to the major efflux systems. In addition to the
core efflux pumps, the TraDISort method identified a large num-
ber of novel genes that are likely to be involved in cell division
and/or aggregation. This application considerably expands the
scope of utility for this method.
To our knowledge, this study represents the first time that
FACS or any other physical selection method has been applied in
parallel with TraDIS to physically enrich for phenotypes of inter-
est in mutant populations prior to sequencing. The results dem-
onstrate the feasibility of this combined approach to generate sta-
tistically significant results and avoid potential false positives that
can arise in traditional fluorescent screening approaches, where
individual strains are isolated and studied. In addition to those
applications described above, we anticipate that FACS applied in
parallel with TraDIS could have a range of additional applications
inmicrobiological research: for example, to rapidly screen satura-
tion mutant libraries carrying fluorescent reporters for genes in-
volved in regulation, to identify the efflux pumps inhibited by
novel efflux inhibitors, and to inform in vitro evolution studies
with fluorescent reporters to identify mutants with improved
metabolic productivity (18).
Ethidium accumulation in isogenic Acinetobacter mutants
measured by flow cytometry. Acinetobacter baumannii AB5075-
UW and Tn26 insertion mutants of adeB (ABUW_1975-150::
T26), adeR (ABUW_1973-195::T26), adeJ (ABUW_0843-122::
T26), adeN (ABUW_1731-148::T26) adeG (ABUW_1335-195::
T26), adeL (ABUW_1338-193::T26), amvA (ABUW_1679-169::
T26), amvR (ABUW_1678-136::T26), craA (ABUW_0337-173::
T26), abeS (ABUW_1343-187::T101), and abeM (ABUW_3486-
184::T26) were obtained from the Manoil lab collection (9). The
strains were grown in Mueller-Hinton (MH; Oxoid) broth with
shaking overnight, diluted 1:100 in freshMH broth, grown to late
exponential phase, and diluted to an optical density at 600 nm
(OD600) of 0.6 inMH broth containing 40Methidium bromide
(Sigma-Aldrich), approximately 1/16 of the MIC for the parental
strain (250 g/ml). This concentration is below the MIC for all
Hassan et al.
















strains tested and provided good fluorescent resolution between
cells differentially expressing an efflux pump. The cells were incu-
bated at room temperature for 20 min and then further diluted to
an OD600 of 0.018 in MH broth containing 40 M ethidium bro-
mide for flow cytometric analyses. The ethidium fluorescence of
10,000 cells from each population was examined on a BD Influx
flow cytometer using a 200-mW 488-nm laser (Coherent Sap-
phire) equipped with a small particle forward scatter detector.
Ethidium bromide fluorescence was detected using a 580/30
bandpass filter. The cells were counted from within populations
gated by forward scatter versus forward scatter pulse width, to
discriminate against aggregated cells, followed by forward and
side scatter to ensure that only living cells of uniform size were
examined (see Fig. S2 in the supplementalmaterial).Acinetobacter
baylyi ADP1 wild type and adeJ and adeN mutants, generated in
our previous studies (5), were examined according to the same
method, except that 15Methidiumbromidewas used due to the
higher susceptibility of this strain to ethidium.
Transposon mutant library generation and verification by
TraDIS. A dense Tn5 mutant library was constructed in A. bau-
mannii BAL062, a global clone II isolate (ENA accession numbers
LT594095 to LT594096), as previously described (6, 7). Briefly, a
custom transposome that included a kanamycin resistance cas-
sette amplified from the pUT-km1 plasmid was generated using
the EZ-Tn5 custom transposome construction kit (Epicentre).
The custom transposome was electroporated into BAL062, and
the cells were plated on kanamycin selective medium (10 mg/
liter). More than 100,000 mutants were collected and stored as
glycerol stocks at 80°C. Aliquots of stock containing approxi-
mately 109 cells were grown overnight in MH broth. Genomic
DNAwas isolated from the cultures, and the transposon insertion
sites were sequenced across four lanes of the Illumina HiSeq se-
quencing system. The insertion sites were mapped and analyzed
statistically using protocols and bioinformatic tools in the TraDIS
toolkit (7). The number of insertions per gene, as a factor of gene
size (insertion index), was calculated for cells grown inMH broth
to illustrate the evenness of transposon insertions across the ge-
nome and to show that the library was sufficiently saturated for
experimental analyses. Insertions at the extreme 3= end (last 10%)
of each gene were filtered since they may not inactivate the gene.
When the data were plotted against frequency, we observed a bi-
modal distribution of insertion indexes in the BAL062 library,
with the peaks correlating with genes that tolerate or do not tol-
erate insertions when cultured under permissive growth condi-
tions (see Fig. S5 in the supplemental material) (19). Using the
method described in reference 20, as executed through the TraDIS
toolbox (7), essential genes were identified as those with an inser-
tion index below 0.0047 (n 475) and were excluded from later
analyses (see Fig. S5). On average, among the nonessential genes
(n  3,362) there were 35.9 unique insertions per kb of gene
sequence (see Fig. S5).
FACS to enrich forA. baumanniimutants showing aberrant
accumulation of ethidium. An aliquot of BAL062 mutant library
stock containing approximately 109 cells was grown overnight in
MH broth. The overnight culture was diluted 1:100 and grown to
late exponential phase (OD600 of 5.5). The cells were diluted to an
OD600 of 0.6 in MH broth containing 40 M ethidium bromide
(approximately 1/16 of the MIC of the parental strain) and then
further diluted 1:100 in 40 M ethidium bromide for FACS. This
concentration of ethidium bromide was used because it provided
excellent differentiation between mutants known to differentially
accumulate ethidium (see Fig. S1 in the supplemental material)
and was well below theMIC of these mutants, so that it would not
cause changes to themutant ratios because of cell death during the
sorting procedure. Cells were sorted using a BD Influx flow cy-
tometer on the basis of ethidium fluorescence (as described
above) using the highest purity mode (1 drop single). Single cells
with uniform forward and side scatter were gated, and pools of the
most highly and weakly fluorescent cells (2% of total single cells)
within this gate were collected in separate tubes containing fresh
MH broth (150,000 to 175,000 cells across four replicates [see
Table S3 in the supplemental material]). The cells collected were
grown overnight, DNA was isolated, and insertion sites were
mapped by TraDIS as described above. Comparisons between ra-
tios of insertion sites in the control and experimental mutant
pools were made using the statistical comparison scripts in the
TraDIS toolbox (7). Genes with fewer than 10 mapped reads in
any data set being compared were excluded from the analyses.
Genes described as being significantly differentially selected be-
tween the control and experimental samples were those showing a
greater than 2-fold change in mutant abundance with a Q value
below 0.05.
For comparison to the FACS-enriched mutants, we also se-
lectedmutants based on their competitive fitness in ethidiumbro-
mide. An aliquot of BAL062 mutant library stock containing ap-
proximately 109 cells was grown overnight in MH broth. The
overnight culture was diluted 1:100 and grown overnight in
62.5g/ml (158.5M) of ethidium bromide (equivalent to 1/4 of
the MIC for the parental strain) to impose a chemical selection
that would allow us to identifymutants with a fitness advantage or
defect in the presence of ethidium bromide. Genomic DNA was
isolated, and the insertion sites were determined by TraDIS. A
replicate experimentwith no ethidiumwas used as the reference in
these experiments.
Accession number(s). The TraDIS sequence data files were
deposited into the European Nucleotide Archive under accession
numbers listed in Table S2 in the supplemental material.
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